Orchestra BioMed Holdings, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $5.86M.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $15.04M.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, new issues for fiscal 2025 was $1.54M, a 89.74% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. stock issued during period, value, new issues for fiscal 2024 was $15.04M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $5.86M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $1.54M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $15.04M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $15.04M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |